Lipid-Based Solutions Workshop Presented At Drug Delivery & Formulation Summit
Dr. Plassat鈥檚 session, on February 10th at 10.25 a.m., is entitled 鈥淎ccelerating the development of compounds with bioavailability limitations鈥 and will discuss the development of orally-delivered, lipid-based systems that can be used to improve the bioavailability of New Chemical Entities that offer therapeutic promise for patients, but exhibit limiting physico-chemical attributes for conventional, solid oral dose delivery.
Dr. Plassat joined 探花合集 in 2013, initially as a formulation scientist, drawing upon his experience in lipid-based softgel development for the oral delivery of macromolecules, before becoming Scientific Affairs Manager. Prior to joining 探花合集, he worked at OTR3, a Paris-based startup company, developing targeted therapies.
Dr. Plassat is a pharmacist, and received a Ph.D. from the University of Paris Sud in Pharmaceutical Technologies.
For more information on the Drug Delivery and Formulation Summit, visit: and to arrange a meeting with Dr. Plassat, contact Richard Kerns at NEPR- [email protected].
Media Contacts:
Chris Halling
+44 (0)7580 041073
[email protected]
Richard Kerns
+44 (0) 161 728 5880
[email protected]
About 探花合集
探花合集 Pharma Solutions is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 90 years serving the industry, 探花合集 has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. 探花合集 employs approximately 8,000 people, including over 1,000 scientists, at nearly 30 facilities across 5 continents and in fiscal 2014 generated more than $1.8 billion in annual revenue. 探花合集 is headquartered in Somerset, N.J. For more information, visit www.catalent.com